Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 No 7416 p275
2 September 2006

This article
Reprint   Photocopy

PDF 110K, Acrobat Reader

Letters

· Asthma
· Homoeopathy
· Controlled drugs
· Compliance aids
· MURs
· Safety (2)
· Retention fees
· The Society (2)


Letters to the Editor

Controlled drugs

New CD regulations — advice please

From Mr F. Royle, MRPharmS and Miss J. Cram, MRPharmS

Recently, the regulations relating to prescriptions for Controlled Drugs were changed, permitting pharmacists to make alterations to otherwise legally valid prescriptions where technical information was missing.

We have some interesting points we would like to share with the wider membership after we both, separately, received incomplete prescriptions for schedule 2 CD medicines. Both the prescriptions in question required the total quantity in words to be added, as permitted by the regulations.

The guidance provided by the Royal Pharmaceutical Society states that the amendment made by the pharmacist must be “attributable to them”. If a pharmacist alters a prescription and a balance is owed, or the stock has to be ordered, how does another pharmacist know who has amended that prescription, and is that pharmacist then obliged to make a supply?

If an alteration is made, and subsequently the patient chooses not to have his or her prescription dispensed at that pharmacy, is the next pharmacist who encounters the prescription obliged to dispense that prescription, given that he or she would not necessarily know who had made the alteration?

A clearly attributable amendment would presumably include a name, registration number and possibly even a contact telephone number and would take up a great deal of space on a prescription if completed properly. Is this practicable? What if the pharmacist who makes the amendment does not make it attributable to them in a clear enough manner?

We would be interested to hear the advice of the Society’s law and ethics department and of any other examples of a similar nature, as we are sure the points we have raised are not exhaustive.

Finlay Royle
Julia Cram

Cardiff

 

PRIYA SEJPAL, professional ethics pharmacist, Royal Pharmaceutical Society, responds:

Following the changes to the Misuse of Drugs Regulations 2001, as amended, pharmacists may make changes to CD prescriptions in certain defined circumstances, where the prescriber’s intentions are absolutely clear. (See PJ, 1 July, pp 25–9 (PDF 90K) or the Society's website (PDF 200K)). The pharmacist must ensure that the prescription is marked so that the amendment is attributable to them. The Regulations do not specify exactly how the prescription should be marked. A pharmacist may write their name, registration number or signature on the prescription, or could alternatively place an asterisk by the change and place a footnote on the script. The Society is currently awaiting further advice from the Home Office on issues surrounding technical errors and a Law and Ethics Bulletin providing further guidance on this will be published in due course.

Send your letter to The Editor

Previous Topic (Homoeopathy)
Next Topic (Compliance aids)

Back to Top


©The Pharmaceutical Journal